K

Kezar Life Sciences
D

KZR

7.60000
USD
0.12
(1.60%)
Market Closed
Volume
79
EPS
-10
Div Yield
-
P/E
-1
Market Cap
55,451,287
OverviewSignalsIdeasNews
Related Instruments
    A
    ADN
    -1.13000
    (-15.80%)
    6.02000 USD
    B
    BGS
    -0.08000
    (-1.27%)
    6.21500 USD
    More
News

Title: Kezar Life Sciences Inc

Sector: Healthcare
Industry: Biotechnology
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.